Semaglutide, the active compound in Wegovy, works by slowing stomach emptying and triggering satiety signals in the brainchanges that typically reduce appetite within days, though visible weight loss follows a predictable timeline
doi:10.1016/S0022-3565(24)38081-4
This same mechanism underlies common GI symptoms, which we mitigate with careful titration
These nanosystems offer a transformative platform for enhancing the pharmacological and biopharmaceutical performance of various drugs, including GLP-1 receptor agonists, which are otherwise limited by poor oral bioavailability, enzymatic degradation, and rapid renal clearance
The characteristic phenotypes observed in infants of mothers, manifesting acute fatty liver of pregnancy, include hepatic encephalopathy presenting with hypoketotic hypoglycemia and sudden onset of liver failure